Project Grant R35GM160328
- The federal Project Grant award of $420,000 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to identify the molecular mechanisms of mitochondrial dysfunction in pathological stress conditions. The primary objective is to investigate the processes of oxidative phosphorylation and mitochondrial membrane potential disruption, which can lead to cell death and tissue damage in various diseases....
- This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $416,050 to The Washington University in University City, Missouri to conduct research on understanding the metabolic and regulatory control of antibiotic production in filamentous actinobacteria. The research aims to investigate two families of antibiotic molecules - polycyclic tetramate macrolactams and...
- The project grant award of $1,925,000 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research to investigate the structural dynamics and regulation of the mitochondrial pyruvate carrier (MPC) at Saint Louis University. The research aims to uncover the conformational changes of the MPC during pyruvate transport and inhibition using electron paramagnetic resonance (EPR) spectroscopy techniques, as...
- This federal Project Grant award of $1,943,750.00, awarded on August 8, 2025, is provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant supports fundamental research and advanced training focused on understanding the molecular mechanisms that regulate the mitotic DNA damage response. The project, led by researchers at The Washington University, aims to 1) reveal how ubiquitinated histone H2A acts...
- This federal Project Grant award for $678,000.00, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research to understand the molecular mechanisms governing the assembly of eukaryotic ribosomes. The research aims to define the co-transcriptional assembly events and transitions towards stable post-transcriptional nucleolar assembly intermediates of ribosomal subunits, leveraging advanced...
- This Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research to investigate how cells respond and adapt to environmental stresses. The $2,777,852 award to The Washington University, located in University City, Missouri, will fund a 4-year research project to study the role of the ribosome and translation factors in mediating stress signaling pathways. The research aims...
- This federal Project Grant award of $237,874 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to investigate the upstream regulation of mitochondrial bioenergetics by the mitochondrial acyl carrier protein (MTACP). The research aims to uncover how MTACP, which sits at the intersection of nutrient inputs and energy expenditure in mitochondria, is regulated through the 4'-phosphopantetheine...
- This $427,625.00 Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research to investigate the molecular mechanisms of compound microtubule structure and function within the mammalian centrosome-cilium complex. The research aims to elucidate how specialized triplet and doublet microtubules, formed with the key proteins delta-tubulin and epsilon-tubulin, contribute to the...
- The National Institute of General Medical Sciences (NIGMS) awarded a $854,927 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Washington University in Missouri. The grant, effective September 5, 2025 through August 31, 2027, will support research to define the mechanisms of a new pathway for genome stability, known as RNA Damage Induced DNA Breaks (RDIBS). The key objectives are to identify the types of RNA modifications that activate RDIBS, the...
- The federal Project Grant award of $248,967.00 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research at the University of Massachusetts aimed at understanding mechanisms that control peroxisomal turnover and how peroxisome dysfunction signals to other cellular organelles. The project, awarded on July 10, 2025, with a completion date of June 30, 2028, will leverage recent findings on the role...
This federal Project Grant award, titled "DECODING MITOCHONDRIAL AAA PROTEASE SPECIFICITY", was provided by the National Institute of General Medical Sciences (CFDA 93.859 - Biomedical Research and Research Training) for $382,931 on September 1, 2025. The award supports fundamental scientific research and advanced training across diverse areas of biomedical science, with a focus on understanding biological processes and developing foundational knowledge for disease diagnosis, treatment, and prevention. The award is being executed by the Washington University, a prestigious private research institution located in Missouri, through its Office of Sponsored Research Services Division. As a leading academic research center, Washington University will leverage its extensive expertise in biomedical sciences, engineering, computational research, and other strategic scientific disciplines to conduct the research project over the performance period ending on August 31, 2030. This federal grant award demonstrates NIGMS's substantial investment in basic biomedical research with potential long-term implications for human health.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $382.9k | 8/12/25 |